Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 213.67
-2.99 (-1.38%)
Aug 21, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 283.58 billion as of August 21, 2026. Its market cap has increased by 11.35% in one year.
Market Cap
283.58B
Enterprise Value
327.14B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
213.67
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 283.58B, an increase of 25.07%. That is a compound annual growth rate of 6.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 283.58B | 24.01% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 484.88B |
| Gland Pharma | 465.09B |
| Ajanta Pharma | 454.74B |
| Emcure Pharmaceuticals | 353.21B |
| Wockhardt | 306.51B |
| Eris Lifesciences | 184.05B |
| Cohance Lifesciences | 181.93B |
| Alivus Life Sciences | 165.81B |